01 January 2018 | News
Dr.Martyn deserved this honor due to his consistently excellent academic and commercial contribution to drug research and pharmaceutical product development and the remarkable contribution he has made to the industry
Juniper Pharmaceuticals a diversified healthcare company , announced that Juniper Pharma Services co-founder Martyn Davies, has been appointed as a Commander of the Order of the British Empire (CBE) in Her Majesty's 2018 New Year's Honours List.
The honors system recognizes people who have made achievements in public life and have committed themselves to serving and helping Britain.
Honorees are proposed by a committee and then approved by the Prime Minister and the Queen.
Dr. Davies will officially receive his CBE medal at an Investiture in 2018.
Dr. Davies has been granted one of the United Kingdom's most prestigious awards in recognition of his contribution to science and his ground-breaking achievements in pharmaceutical research and drug development.
Now an advisor to the board of Juniper Pharmaceuticals and Chair of Juniper's Scientific Advisory Board, Dr. Davies is also an Emeritus Professor at the School of Pharmacy within The University of Nottingham.
Dr. Davies co-founded Molecular Profiles (now Juniper Pharma Services) in 1997.
He has played a significant role in the contract development and built-up organization's rapid growth and expansion over the last 20 years.
He worked on several hundred products, including over half of the world's top 20 blockbuster drugs.
In 2013, the company was acquired by Columbia Laboratories (now Juniper Pharmaceuticals).
Dr. Davies originally qualified as a pharmacist, with first-class honors before earning his PhD from the Chelsea School of Pharmacy in 1984.
During his academic career, Dr. Davies has published 425 scientific papers and supervised over 70 PhD students and mentored over 40 postdoctoral fellows.
He is a Fellow of the Controlled Release Society, UK Association of Pharmaceutical Scientists, Royal Society of Chemistry, American Institute of Biological Engineering and Royal Pharmaceutical Society of Great Britain.
Dr. Davies is also the part of editorial boards of many journals including the Journal of Controlled Release, Journal of Pharmaceutical Sciences and European Journal of Pharmaceutical Sciences.